Therefore, 75 boosted the human colon cancer cells’ sensitivity to TRAIL-caused apoptosis via the ERK-ROS/CHOP-p38 MAPK–mediated upregulation of DR4 and DR5 expression, indicating that 75 could be developed into a chemotherapeutic agent [42]. The gene discussed is TNFSF10; the disease is colonic neoplasm.